Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro
- Resource Type
- Article
- Source
- In
International Immunopharmacology 20 April 2024 131 - Subject
- Language
- ISSN
- 1567-5769